TREM2 and acute myeloid leukemia: In acute myeloid leukemia (AML), Xie et al. [38] reported that the binding of IL-34 to Trem2 can inactivate the extracellular signal-regulated protein kinase 1/2 signaling pathway, thus inhibiting the proliferation and differentiation of AML cells.